Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

No evidence for essential differences between the effects of insulin glargine, insulin detemir and NPH [neutral protamine Hagedorn] insulin on glucose metabolism after a single injection as assessed by 24-h euglycemic clamp studies in healthy humans

Trial Profile

No evidence for essential differences between the effects of insulin glargine, insulin detemir and NPH [neutral protamine Hagedorn] insulin on glucose metabolism after a single injection as assessed by 24-h euglycemic clamp studies in healthy humans

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin glargine; Insulin suspension isophane
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 07 Nov 2012 Planned number of patients changed from 10 to 12 as reported by European Clinical Trials Database.
    • 01 Jul 2010 Actual volunteer numbers reported as 10
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top